Vestcor Inc Sells 6,700 Shares of National Research Co. (NASDAQ:NRC)

Vestcor Inc trimmed its position in shares of National Research Co. (NASDAQ:NRC) by 74.9% during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund owned 2,251 shares of the company’s stock after selling 6,700 shares during the quarter. Vestcor Inc’s holdings in National Research were worth $51,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC increased its holdings in shares of National Research by 889.7% in the 2nd quarter. CWM LLC now owns 1,158 shares of the company’s stock worth $27,000 after purchasing an additional 1,041 shares in the last quarter. Quarry LP purchased a new stake in shares of National Research during the second quarter valued at $54,000. Benjamin F. Edwards & Company Inc. increased its holdings in National Research by 145.6% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 2,783 shares of the company’s stock worth $64,000 after buying an additional 1,650 shares in the last quarter. FMR LLC raised its position in National Research by 397.3% in the 3rd quarter. FMR LLC now owns 2,944 shares of the company’s stock worth $67,000 after buying an additional 2,352 shares during the last quarter. Finally, Gladius Capital Management LP lifted its stake in National Research by 164.5% during the 3rd quarter. Gladius Capital Management LP now owns 3,068 shares of the company’s stock valued at $70,000 after acquiring an additional 1,908 shares during the period. 47.26% of the stock is currently owned by institutional investors.

National Research Stock Performance

Shares of NRC stock opened at $17.79 on Friday. The company has a quick ratio of 0.47, a current ratio of 0.47 and a debt-to-equity ratio of 1.30. The company has a 50 day moving average price of $19.16 and a 200-day moving average price of $21.90. National Research Co. has a 52 week low of $17.62 and a 52 week high of $42.18. The firm has a market capitalization of $417.64 million, a PE ratio of 15.74 and a beta of 0.52.

National Research (NASDAQ:NRC) last posted its earnings results on Friday, October 25th. The company reported $0.24 EPS for the quarter. The business had revenue of $35.82 million during the quarter. National Research had a net margin of 18.78% and a return on equity of 67.40%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be paid a dividend of $0.12 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.70%. National Research’s dividend payout ratio is currently 42.48%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.